AMN Healthcare Swings to $88M Loss Amid Impairments, Revenue Dip

TL;DR

**AMN's massive goodwill impairment and revenue drop make it a clear sell, despite a Q3 gain from asset sales.**

AI Summary

AMN Healthcare Services Inc. reported a significant financial downturn for the nine months ended September 30, 2025, with revenue decreasing to $1,982,204 thousand from $2,249,072 thousand in the prior year, a 11.87% decline. The company posted a net loss of $88,006 thousand, a stark contrast to the net income of $40,554 thousand for the same period in 2024. This loss was primarily driven by a goodwill impairment loss of $109,515 thousand and a long-lived assets impairment loss of $18,262 thousand. Despite the nine-month loss, the third quarter showed a net income of $29,288 thousand, up from $6,989 thousand in Q3 2024, partly due to a $39,180 thousand gain on the sale of its Smart Square healthcare scheduling software. Cash and cash equivalents increased to $52,636 thousand from $10,649 thousand at December 31, 2024, while total assets decreased by 11.46% to $2,138,951 thousand. The company also reduced its revolving credit facility balance from $210,000 thousand to zero, indicating a focus on debt reduction.

Why It Matters

AMN's substantial net loss and revenue decline signal a challenging environment for healthcare staffing, impacting investor confidence and potentially leading to strategic shifts. The goodwill impairment of $109,515 thousand suggests a re-evaluation of past acquisitions, which could affect future M&A activity and shareholder value. For employees, a contracting market might mean fewer opportunities or increased pressure. Customers, particularly healthcare providers, could see changes in staffing availability or pricing as AMN adjusts its operations. In a competitive landscape, this downturn could allow rivals to gain market share if AMN struggles to adapt to evolving healthcare demands.

Risk Assessment

Risk Level: high — The company reported a net loss of $88,006 thousand for the nine months ended September 30, 2025, a significant deterioration from a $40,554 thousand net income in the prior year. This was largely due to a goodwill impairment loss of $109,515 thousand and a long-lived assets impairment loss of $18,262 thousand, indicating fundamental issues with asset valuation and business performance.

Analyst Insight

Investors should consider divesting AMN shares given the significant net loss, goodwill impairment, and declining revenue trends. Monitor future filings for signs of stabilization in core business segments and a clear strategy to address the underlying issues that led to the impairment charges.

Financial Highlights

debt To Equity

2.32

revenue

$1,982,204

operating Margin

N/A

total Assets

$2,138,951

total Debt

$1,494,542

net Income

$(88,006)

eps

$(2.29)

gross Margin

29.21%

cash Position

$52,636

revenue Growth

-11.87%

Key Numbers

• $1,982,204 — Revenue (9 months) (Decreased from $2,249,072 thousand in 2024, an 11.87% decline.)
• $(88,006) — Net Income (Loss) (9 months) (Swung from a $40,554 thousand net income in 2024 to a significant loss.)
• $109,515 — Goodwill Impairment Loss (Major contributor to the net loss for the nine months ended September 30, 2025.)
• $39,180 — Gain on Sale of Disposal Group (Partially offset losses in Q3 2025, from the sale of Smart Square software.)
• $52,636 — Cash and Cash Equivalents (Increased significantly from $10,649 thousand at December 31, 2024.)
• $210,000 — Revolving Credit Facility (Reduced from $210,000 thousand at December 31, 2024, to zero by September 30, 2025.)
• $2,138,951 — Total Assets (Decreased by 11.46% from $2,415,727 thousand at December 31, 2024.)
• $0.76 — Diluted EPS (Q3) (Increased from $0.18 in Q3 2024, driven by the Smart Square sale gain.)
• $(2.29) — Diluted EPS (9 months) (Decreased from $1.06 in 2024, reflecting the overall net loss.)
• $18,262 — Long-lived Assets Impairment Loss (Contributed to the overall net loss for the nine months ended September 30, 2025.)

Key Players & Entities

• AMN Healthcare Services, Inc. (company) — Registrant
• KPMG LLP (company) — Auditor
• Smart Square (company) — healthcare scheduling software sold by AMN
• $88,006 thousand (dollar_amount) — Net loss for the nine months ended September 30, 2025
• $109,515 thousand (dollar_amount) — Goodwill impairment loss for the nine months ended September 30, 2025
• $1,982,204 thousand (dollar_amount) — Revenue for the nine months ended September 30, 2025
• $2,249,072 thousand (dollar_amount) — Revenue for the nine months ended September 30, 2024
• $39,180 thousand (dollar_amount) — Gain on sale of disposal group (Smart Square) for the three months ended September 30, 2025
• $65,320 (dollar_amount) — Cash consideration received from the sale of Smart Square
• $210,000 (dollar_amount) — Revolving credit facility balance at December 31, 2024, reduced to zero by September 30, 2025

FAQ

Risk Factors

• Goodwill and Intangible Asset Impairment [high — financial]: The company recorded significant impairment losses totaling $109,515 thousand for goodwill and $18,262 thousand for long-lived assets in the nine months ended September 30, 2025. These impairments reflect a substantial decline in the carrying value of these assets, indicating potential overvaluation or a deterioration in the expected future economic benefits from past acquisitions.
• Revenue Decline [high — financial]: Revenue decreased by 11.87% to $1,982,204 thousand for the nine months ended September 30, 2025, compared to $2,249,072 thousand in the prior year. This significant drop suggests challenges in market demand, competitive pressures, or execution issues within the company's core business.
• Shift to Net Loss [high — financial]: The company swung from a net income of $40,554 thousand in the nine months ended September 30, 2024, to a net loss of $88,006 thousand in the same period of 2025. This substantial negative shift, exacerbated by impairment charges, raises concerns about profitability and financial stability.
• Asset Valuation Reduction [medium — financial]: Total assets decreased by 11.46% to $2,138,951 thousand as of September 30, 2025, from $2,415,727 thousand at December 31, 2024. This reduction is largely due to the aforementioned asset impairments and a decrease in accounts receivable, indicating a contraction in the company's balance sheet.
• Debt Reduction Strategy [medium — financial]: The company eliminated its $210,000 thousand revolving credit facility balance by September 30, 2025. While this demonstrates a commitment to deleveraging, it also suggests a potential need to conserve cash or a reduced reliance on short-term financing.

Industry Context

AMN Healthcare operates in the highly competitive healthcare staffing industry, which is sensitive to labor shortages, regulatory changes, and economic conditions. The demand for healthcare professionals, particularly nurses and allied health staff, remains a key driver, but the industry also faces challenges related to contract labor costs and the increasing adoption of technology in workforce management.

Regulatory Implications

The healthcare industry is subject to extensive regulation, including compliance with labor laws, healthcare quality standards, and data privacy regulations (like HIPAA). Changes in reimbursement policies or staffing mandates could impact demand for staffing services. AMN's operations require continuous monitoring to ensure adherence to these evolving regulatory landscapes.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-09-30: Nine Months Ended — Reported significant revenue decline and net loss, primarily due to goodwill and long-lived asset impairments.
• 2025-09-30: Third Quarter Ended — Showed a net income increase driven by a gain on the sale of Smart Square software, contrasting with the nine-month performance.
• 2025-09-30: Revolving Credit Facility Balance — Reduced to zero, indicating a focus on debt reduction and improved liquidity management.
• 2024-12-31: Year End — Previous period's financial standing, with higher revenue, net income, and a $210,000 thousand revolving credit facility balance.

Glossary

Goodwill Impairment Loss

A charge taken when the carrying value of goodwill on the balance sheet exceeds its fair value, indicating that the acquired business is not performing as expected. (A major contributor to AMN's net loss for the nine months ended September 30, 2025, signaling issues with past acquisitions.)

Long-lived Assets Impairment Loss

A charge recognized when the carrying amount of a long-lived asset (like property, plant, or equipment) is not recoverable, meaning its future economic benefits are less than its book value. (Contributed to the overall net loss for AMN in the nine months ended September 30, 2025.)

Gain on Sale of Disposal Group

Profit recognized from selling a part of the business or assets that are classified as held for sale. (The $39,180 thousand gain from selling Smart Square software helped offset losses in Q3 2025.)

Treasury Stock

Stock that a company has repurchased from the open market. It is recorded at cost and reduces total stockholders' equity. (AMN holds a significant amount of treasury stock ($1,127,043 thousand), which impacts its equity position.)

Accumulated Other Comprehensive Income (Loss)

Includes unrealized gains and losses that are not reported on the income statement but affect equity, such as foreign currency translation adjustments. (AMN shows a small positive balance of $275 for this item as of September 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year's nine months, AMN Healthcare Services Inc. experienced a significant downturn, with revenue falling 11.87% to $1,982,204 thousand and a net loss of $88,006 thousand replacing a net income of $40,554 thousand. This shift was heavily influenced by substantial goodwill ($109,515 thousand) and long-lived asset ($18,262 thousand) impairment charges. While total assets decreased by 11.46%, cash and cash equivalents saw a substantial increase to $52,636 thousand, and the company eliminated its $210,000 thousand revolving credit facility, indicating a focus on strengthening its balance sheet despite operational challenges.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value AMN New York Stock Exchange

Filing Documents

• amn-20250930.htm (10-Q) — 1410KB
• amn-ex311x20250930x10q.htm (EX-31.1) — 10KB
• amn-ex312x20250930x10q.htm (EX-31.2) — 10KB
• amn-ex321x20250930x10q.htm (EX-32.1) — 6KB
• amn-ex322x20250930x10q.htm (EX-32.2) — 5KB
• amn-20250930_g1.jpg (GRAPHIC) — 49KB
• 0001628280-25-050362.txt ( ) — 7560KB
• amn-20250930.xsd (EX-101.SCH) — 35KB
• amn-20250930_cal.xml (EX-101.CAL) — 89KB
• amn-20250930_def.xml (EX-101.DEF) — 165KB
• amn-20250930_lab.xml (EX-101.LAB) — 547KB
• amn-20250930_pre.xml (EX-101.PRE) — 389KB
• amn-20250930_htm.xml (XML) — 1399KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1. Condensed Consolidated Financial Statements (unaudited): 1 Condensed Consolidated Balance Sheets, As of September 30 , 2025 and December 31, 2024 1 Condensed Consolidated Statements of Comprehensive Income (Loss), For the Three and Nine Months Ended September 30, 2025 and 2024 2 Condensed Consolidated Statements of Stockholders' Equity, For the Nine Months Ended September 30, 2025 and 2024 3 Condensed Consolidated Statements of Cash Flows, For the Nine Months Ended September 30, 2025 and 2024 5 Notes to Unaudited Condensed Consolidated Financial Statements 7 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 22 3. Quantitative and Qualitative Disclosures about Market Risk 33 4. Controls and Procedures 34

- OTHER INFORMATION

PART II - OTHER INFORMATION 1. Legal Proceedings 35 1A. Risk Factors 35 2. Unregistered Sales of Equity Securities and Use of Proceeds 35 3. Defaults Upon Senior Securities 35 4. Mine Safety Disclosures 35 5. Other Information 35 6. Exhibits 36

Signatures

Signatures 37 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements AMN HEALTHCARE SERVICES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands, except par value) September 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 52,636 $ 10,649 Accounts receivable, net of allowances of $ 17,379 and $ 32,421 at September 30, 2025 and December 31, 2024, respectively 391,100 437,817 Accounts receivable, subcontractor 51,610 70,481 Prepaid expenses 18,088 22,510 Other current assets 56,889 53,458 Total current assets 570,323 594,915 Restricted cash, cash equivalents and investments 44,362 71,840 Fixed assets, net of accumulated depreciation of $ 397,204 and $ 360,795 at September 30, 2025 and December 31, 2024, respectively 146,979 186,270 Other assets 276,764 258,053 Deferred income taxes, net 42,637 25,829 Goodwill 755,809 897,456 Intangible assets, net of accumulated amortization of $ 545,432 and $ 534,822 at September 30, 2025 and December 31, 2024, respectively 302,077 381,364 Total assets $ 2,138,951 $ 2,415,727 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 171,135 $ 184,311 Accrued compensation and benefits 293,182 287,544 Other current liabilities 77,845 73,930 Total current liabilities 542,162 545,785 Revolving credit facility — 210,000 Notes payable, net of unamortized fees and premium 846,759 845,872 Other long-term liabilities 105,621 107,450 Total liabilities 1,494,542 1,709,107 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; 10,000 shares authorized; none issued and outstanding at September 30, 2025 and December 31, 2024 — — Common stock, $ 0.01 par value; 200,000 shares authorized; 50,944 issued and 38,331 outstanding at September 30, 2025 and 50,692 issued and 38,079 outstanding at December 31, 2024 509 507 Additional paid-in capital 553,978 528,471 Treasury stock, at cost; 12,613 shares at S